ARK GENOMIC REVOLUTION ETFETF · US00214Q3020 · ARKG (BATS)ARK · TER 0,75 % · United States · Financial Services — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Company Profile for ARK GENOMIC REVOLUTION ETF ETF
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.
Updated on Jun 27 2026, 4:00 AM
Company Data
NameARK GENOMIC REVOLUTION ETF
CompanyARK Genomic Revolution ETF
SymbolARKG
Primary Exchange
BATS
ISINUS00214Q3020
Asset ClassETF
SectorFinancial Services
IndustryAsset Management
Market Capitalization870 Mio
CountryUnited States
CurrencyUSD
Employees-
IPO Date2014-10-31
Dividends from 'ARK GENOMIC REVOLUTION ETF'
Ex-Date
Dividend per Share
29.12.2021
0,38 USD
29.12.2020
0,79 USD
27.12.2019
1,05 USD
27.12.2018
0,20 USD
27.12.2017
0,33 USD
Ticker Symbols
Name
Symbol
Hamburg
ARKGRE20.HAMB
NYSE
ARKG
More Shares
Investors who hold ARK GENOMIC REVOLUTION ETF also have the following shares in their portfolio:
